@FierceBiotech: PharmAthene scraps Theraclone merger after feds nix funding. More | Follow @FierceBiotech
@JohnCFierce: Forest Labs takes aim at R&D in $500M cost-cutting blitz. News | Follow @JohnCFierce
@DamianFierce: Aptuit poached a former $ICLR VP to serve as next CEO. Story | Follow @DamianFierce
@EmilyMFierce: Novartis announced on Thanksgiving that its scientists have discovered a new malaria target. Release | Follow @EmilyMFierce
> South San Francisco-based Exelixis ($EXEL) launched a Phase II clinical trial comparing cabozantinib plus abiraterone and prednisone versus abiraterone/prednisone in patients with castration-resistant prostate cancer who have bone metastases and have not been previously treated with chemotherapy. The primary endpoint is radiographic progression-free survival. Release
> Greenwich, CT-based Aptuit has named Jonathan Goldman, a veteran of ICON ($ICLR), as the new CEO. Story
@FierceMedDev: Report: Insurers could gain up to $1B in J&J hip settlement deal. Item | Follow @FierceMedDev
@MarkHFierce: LabCorp has become the latest to roll out new BRCA tests - wondering when Myriad will sue them, too. Release | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Study: Natural nanomaterials could support biodegradable drug delivery. Story | Follow @MichaelGFierce
@GalenMoore: Infectious-disease biotech Visterra has raised $8.1M and licensed dengue-fever IP from its co-founder's lab at MIT. More | Follow @GalenMoore
> HeartWare bags CircuLite for up to $350M with eye on bigger market share. Article
> University of Toronto molecular Dx spinout pulls in $18.8M Series B. Report
> NEJM study ties Thoratec's HeartMate pump to blood clots. More
> Ardian vet, early Google employee post $3.8M for stealthy med tech startup. Story
> Abbott recalls glucose test strips over risk with older-model meters. Piece
Pharma News
@FiercePharma: Irish plant shutdown puts another Merck site on the block. Story from FiercePharmaManufacturing | Follow @FiercePharma
@EricPFierce: Analysts predicted Forest would do something to cut costs. Here it is. Release | Follow @EricPFierce
@CarlyHFierce: This disease database digitization project is named for Tycho Brahe, Prague's imperial astronomer in the late 1500s. Story | Follow @CarlyHFierce
> KKR bets $200M on India's Gland Pharma. News
> Glaxo CEO Witty visits China in wake of bribery charges. Story
> Japan's Takeda looks to outsider as it reaches for international status. More
Biotech IT News
> Computational biology startup joins Merck KGaA's incubator. More
> Digitization work turns 125 years of disease reports into Big Data goldmine. News
> Pfizer: 'Bring your own device' is coming to clinical trials. Story
> Academics dig into EMRs to discover genetic causes of disease. Article
> Report suggests biopharma wise to outsource cybersecurity. Piece
> Sony files patent for wearable computing 'SmartWig'. Item
CRO News
> Analyst: Pharma R&D cuts won't hamper big CROs. Story
> Almac banks $9M in diagnostics deal with Genomic Health. More
> CRO SillaJen eyes $150M deal for ex-sponsor. News
> Evoke picks SynteractHCR to helm PhIII for diabetes drug. Piece
> Aptuit snags ex-Icon exec to serve as CEO. Article
> Parexel: Strategic partnerships are the future. Item